Colgate-Palmolive (NYSE:CL) Shares Purchased by LGT Capital Partners LTD.

LGT Capital Partners LTD. raised its holdings in shares of Colgate-Palmolive (NYSE:CL - Free Report) by 26.3% in the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 1,252,010 shares of the company's stock after acquiring an additional 260,620 shares during the period. Colgate-Palmolive makes up 4.3% of LGT Capital Partners LTD.'s holdings, making the stock its 7th largest position. LGT Capital Partners LTD. owned 0.15% of Colgate-Palmolive worth $113,820,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in the business. State Street Corp increased its holdings in Colgate-Palmolive by 3.8% during the 3rd quarter. State Street Corp now owns 48,436,276 shares of the company's stock worth $5,028,170,000 after purchasing an additional 1,784,411 shares in the last quarter. Geode Capital Management LLC increased its holdings in Colgate-Palmolive by 2.8% during the 3rd quarter. Geode Capital Management LLC now owns 20,193,331 shares of the company's stock worth $2,095,325,000 after purchasing an additional 552,949 shares in the last quarter. Massachusetts Financial Services Co. MA increased its holdings in Colgate-Palmolive by 6.2% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 9,526,990 shares of the company's stock worth $988,997,000 after purchasing an additional 557,492 shares in the last quarter. Amundi increased its holdings in Colgate-Palmolive by 12.8% during the 4th quarter. Amundi now owns 9,200,144 shares of the company's stock worth $806,015,000 after purchasing an additional 1,040,604 shares in the last quarter. Finally, Barclays PLC increased its holdings in Colgate-Palmolive by 38.7% during the 3rd quarter. Barclays PLC now owns 7,644,189 shares of the company's stock worth $793,542,000 after purchasing an additional 2,132,747 shares in the last quarter. Institutional investors own 80.41% of the company's stock.

Remove Ads

Colgate-Palmolive Stock Performance

NYSE:CL traded up $0.72 during mid-day trading on Monday, hitting $97.46. The stock had a trading volume of 9,790,594 shares, compared to its average volume of 4,160,466. Colgate-Palmolive has a twelve month low of $85.32 and a twelve month high of $109.30. The stock has a market cap of $79.09 billion, a price-to-earnings ratio of 27.69, a PEG ratio of 4.20 and a beta of 0.40. The company's 50 day simple moving average is $88.97 and its 200 day simple moving average is $95.06. The company has a debt-to-equity ratio of 13.40, a quick ratio of 0.58 and a current ratio of 0.92.

Colgate-Palmolive (NYSE:CL - Get Free Report) last issued its quarterly earnings data on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same quarter in the prior year, the firm earned $0.87 earnings per share. On average, equities research analysts forecast that Colgate-Palmolive will post 3.75 earnings per share for the current year.

Colgate-Palmolive Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st were given a dividend of $0.50 per share. The ex-dividend date of this dividend was Tuesday, January 21st. This represents a $2.00 annualized dividend and a yield of 2.05%. Colgate-Palmolive's dividend payout ratio (DPR) is presently 56.82%.

Analysts Set New Price Targets

CL has been the subject of a number of research reports. Stifel Nicolaus lowered their target price on Colgate-Palmolive from $95.00 to $93.00 and set a "hold" rating for the company in a report on Monday, February 3rd. UBS Group lowered their target price on Colgate-Palmolive from $104.00 to $100.00 and set a "buy" rating for the company in a report on Monday, February 3rd. Piper Sandler reduced their price objective on shares of Colgate-Palmolive from $121.00 to $112.00 and set an "overweight" rating for the company in a research note on Monday, January 6th. Wells Fargo & Company reduced their price objective on shares of Colgate-Palmolive from $92.00 to $83.00 and set an "underweight" rating for the company in a research note on Tuesday, January 7th. Finally, Raymond James restated an "outperform" rating and set a $105.00 price objective (down from $110.00) on shares of Colgate-Palmolive in a research note on Monday, February 3rd. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and twelve have given a buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average price target of $101.61.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.